| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.062 | 0.03 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |